Cite
HARVARD Citation
Glicksman, R. et al. (2022). Absolute Percentage of Pattern 4 Disease as a Prognostic Measure for Intermediate-risk Prostate Cancer Treated with Stereotactic Body Radiotherapy. Clinical oncology. 34 (9), pp. 581-588. [Online].